A Multicenter Prospective Real-World Effectiveness and Safety of Satralizumab in the Early Treatment of Attacks in NMOSD | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Multicenter Prospective Real-World Effectiveness and Safety of Satralizumab in the Early Treatment of Attacks in NMOSD	CNS demyelinating autoimmune disease, acute transverse myelitis, autoimmune disease, autoimmune disorder of the nervous system, cranial nerve neuropathy, demyelinating disease, eye disorder, immune system disorder, nervous system disorder, neuromyelitis optica, optic nerve disorder, optic neuritis	Recruiting	Not stated	2026-08-13		NCT07762872

6 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Chifeng Municipal Hospital	3
First Affiliated Hospital of Harbin Medical University	64
Junwei Hao, MD	1
Shandong Provincial Hospital	112
The First Hospital of Hebei Medical University	18
The Second Hospital of Hebei Medical University	26

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Xuanwu Hospital Capital Medical University	Beijing	China	22